3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Motor Activity
35
Breast Neoplasms
20
Neoplasms
19
Fatigue
9
Prostatic Neoplasms
4
Lung Neoplasms
4
Hematologic Neoplasms
4
Colorectal Neoplasms
4
Obesity
3
Weight Loss
2
Smoking
2
Sedentary Behavior
2
Postoperative Complications
2
Ovarian Neoplasms
2
Mixed Cancer
2
Lymphedema
2
Frailty
2
Colonic Neoplasms
2
Cardiotoxicity
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urologic Neoplasms
1
Urinary Incontinence
1
Stomach Neoplasms
1
Sarcoma
1
Risk Reduction Behavior
1
Rehabilitation After Lung Cancer Surgery
1
Interventions
Cisplatin
44
Paclitaxel
21
Radiotherapy
20
Brachytherapy
19
Carboplatin
18
Bevacizumab
7
Drug Therapy
6
camrelizumab
5
toripalimab
4
nimotuzumab
4
Radiation
4
Neoadjuvant Therapy
4
Gemcitabine
4
tislelizumab
3
sintilimab
3
pembrolizumab
3
apatinib
3
Vaccines
3
TP protocol
3
Surgical Procedures, Operative
3
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
3
nedaplatin
2
fludarabine
2
endostar protein
2
anlotinib
2
Topotecan
2
Surveys and Questionnaires
2
Sentinel Lymph Node Biopsy
2
Radiotherapy, Intensity-Modulated
2
Mindfulness
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Uterine Cervical Neoplasms
×
Exercise
×
Clear all
NCT05561413
2022-10-03
GEMS
University of Ulster
Phase NA
Unknown
40 enrolled